CLINICAL EFFICACY OF ENDOSCOPIC RESECTION IN GASTRIC CANCER
Abstract
Providing clinical, robust, and long-term medical care—based on modern scientific sources—utilizing endoscopic resection techniques (EMR and ESD) for early-stage cancer.
References
Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) // Gastric Cancer. — 2023. — Vol. 26, № 1. — P. 1–25.
Ono H., Yao K., Fujishiro M., et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition) // Dig. Endosc. — 2021. — Vol. 33, № 1. — P. 4–20.
Lian J., Chen S., Zhang Y., Qiu F. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer // Gastrointest. Endosc. — 2012. — Vol. 76, № 4. — P. 763–770.
Hasuike N., Ono H., Boku N., et al. A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607) // Gastric Cancer. — 2018. — Vol. 21, № 1. — P. 114–123.
Hatta W., Gotoda T., Koike T., et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: «eCura system» // Am. J. Gastroenterol. — 2017. — Vol. 112, № 6. — P. 874–881.
Fukase K., Kato M., Kikuchi S., et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial // Lancet. — 2008. — Vol. 372, № 9636. — P. 392–397.
